Umelisa SARS-COV-2 antigen, a 100 % Cuban diagnostic system

Havana, July 5 (RHC)--  The  Immunoassay Center has developed a new product to diagnose the Sars-Cov-2 virus.

Under the brand name Umelisa, after extensive tests, the kit will soon be integrated into the sanitary and virus detection protocols in Cuba.

According to a report by Cubavisión Internacional, the product was validated by the Pedro Kourí Institute of Tropical Medicine. The Center for State Control of Medicines, Equipment, and Medical Devices (CECMED), has already registered it.

According to Irina Valdivia Álvarez, deputy director of the Diagnostics Development and Production area, the test performed with this technology identifies the virus presence in asymptomatic suspect patients in just four hours.

She added that it is a 100% Cuban technology, both the kit and the raw materials used for its development and production.

Valdivia Alvarez said that its presence on the island’s health system would allow more than 705,000 diagnostic tests.